Nanoviricides (NNVC) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Nanoviricides in November 2026.
NanoViricides, Inc. is a clinical-stage company. The Company is engaged in developing a class of drugs that it calls nanoviricides, using a platform technology based on the application of nanomedicine technologies to the complex issues of viral diseases. Its lead drug candidate is NV-387, a broad-spectrum antiviral drug that has demonstrated activity in lethal lung infection animal model studies of Coronavirus (COVID), Respiratory Syncytial Virus, Influenza, Orthopoxvirus model for Smallpox and MPox, and even in a humanized mice model for Measles. It is focused on advancing Phase II clinical trials. Its other advanced drug candidate is NV-HHV-1 for the treatment of Shingles rash. Its NV-CoV-2 and NV-CoV-2-R are drug candidates for the treatment of COVID. Its portfolio also includes NV-HIV-1, a novel mechanism Anti-HIV Drug Candidate. Its other drug candidates include treatment for viral infections, including Dengue viruses, Ebola viruses, among others.
Nanoviricides (NNVC) Stock Forecast
Analyst price target, next 12 months
$6.50
+342.2% vs today's $1.47
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Nanoviricides have a consensus 12-month target of $6.50, above the current price of $1.47.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 30 Sep 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying shares of Nanoviricides, expecting the price to rise significantly.
Financial Health
NANOVIRICIDES INC has a modest book value and cash flow, indicating stable but limited financial strength.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
